APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 8, 2013, Pages 1361-1369

  Bangen, Katherine J ^a   Beiser, Alexa ^b,c,d   Delano Wood, Lisa ^a,e   Nation, Daniel A ^e   Lamar, Melissa ^f   Libon, David J ^g   Bondi, Mark W ^a,e   Seshadri, Sudha ^b,c   Wolf, Philip A ^b,c   Au, Rhoda ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

aging; Apolipoprotein E; cardiovascular disease; cognition; diabetes; hypertension; vascular risk

Indexed keywords

ADULT; ALLELE; APOLIPOPROTEIN E EPSILON4 GENE; ARTICLE; ATTENTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DEPTH PERCEPTION; FEMALE; GENE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDLIFE VASCULAR RISK; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VERBAL MEMORY; AGED; COGNITION DISORDERS; FOLLOW UP; GENETICS; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; RISK FACTOR; SOCIOECONOMICS; VASCULAR DISEASES; VERY ELDERLY;

APOLIPOPROTEIN E;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; RISK FACTORS; SOCIOECONOMIC FACTORS; VASCULAR DISEASES;

EID: 84889074196     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.013     Document Type: Article

References (36)

1. S. Debette, S. Seshadri, and A. Beiser Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline Neurology 77 2011 461 468
2. A. Alonso, T.H. Mosley Jr., and R.F. Gottesman Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study J Neurol Neurosurg Psychiatry 80 2009 1194 1201
3. M. Kivipelto, T. Ngandu, and T. Laatikainen Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study Lancet Neurol 5 2006 735 741
4. D.A. Nation, C.E. Wierenga, and L. Delano-Wood Elevated pulse pressure is associated with age-related decline in language ability J Int Neuropsychol Soc 16 2010 933 938
5. Y.D. Reijmer, E. van den Berg, and S. van Sonsbeek Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population Dement Geriatr Cogn Disord 31 2011 152 157
6. D. Carmelli, G.E. Swan, and T. Reed Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins Neurology 50 1998 1580 1585
7. E.H. Corder, A.M. Saunders, and W.J. Strittmatter Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
8. J. Davignon, R.E. Gregg, and C.F. Sing Apolipoprotein E polymorphism and atherosclerosis Arteriosclerosis 8 1988 1 21
9. Y.F. Chuang, K.M. Hayden, and M.C. Norton Association between APOE epsilon4 allele and vascular dementia: The Cache County study Dement Geriatr Cogn Disord 29 2010 248 253
10. B.J. Small, C.B. Rosnick, and L. Fratiglioni Apolipoprotein E and cognitive performance: a meta-analysis Psychol Aging 19 2004 592 600
11. A.F. Jorm, K.A. Mather, and P. Butterworth APOE genotype and cognitive functioning in a large age-stratified population sample Neuropsychology 21 2007 1 8
12. M.W. Bondi, D.P. Salmon, and D. Galasko Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease Psychology Aging 14 1999 295 303
13. M.N. Haan, L. Shemanski, and W.J. Jagust The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons JAMA 282 1999 40 46
14. S. Kalmijn, E.J. Feskens, and L.J. Launer Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men Stroke 27 1996 2230 2235
15. D.S. Knopman, T.H. Mosley, D.J. Catellier Atherosclerosis Risk in Communities Study Brain MRIS Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study Alzheimers Dementia 5 2009 207 214
16. R.A. Sperling, P.S. Aisen, and L.A. Beckett Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimer Dementia 7 2011 280 292
17. M. Feinleib, W.B. Kannel, R.J. Garrison The Framingham Offspring Study Design and preliminary data Prev Med 4 1975 518 525
18. A.V. Chobanian, G.L. Bakris, and H.R. Black Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
19. P.A. Wolf, R.B. D'Agostino, and A.J. Belanger Probability of stroke: a risk profile from the Framingham Study Stroke 22 1991 312 318
20. R.K. Heaton, L.M. Nelson, and D.S. Thompson Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis J Consult Clin Psychol 53 1985 103 110
21. R.E. Pitas, J.K. Boyles, and S.H. Lee Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain J Biol Chem 262 1987 14352 14360
22. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 240 1988 622 630
23. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 103 2006 5644 5651
24. T. Wisniewski, E.M. Castano, and A. Golabek Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am J Pathol 145 1994 1030 1035
25. R.W. Mahley, and Y. Huang Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology Acta Neurol Scand Suppl 185 2006 8 14
26. A.J. Jak, D.A. Nation, and L. Delano-Wood Relationship between vascular risk factors and mild cognitive impairment Cogn Sci 5 2011 99 124
27. S.E. Humphries, and L. Morgan Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches Lancet Neurol 3 2004 227 235
28. G. Kolovou, D. Daskalova, and D.P. Mikhailidis Apolipoprotein E polymorphism and atherosclerosis Angiology 54 2003 59 71
29. M.O. McCarron, D. Delong, and M.J. Alberts APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis Neurology 53 1999 1308 1311
30. P.B. Gorelick, A. Scuteri, and S.E. Black Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 2672 2713
31. J.A. Schneider, N.T. Aggarwal, and L. Barnes The neuropathology of older persons with and without dementia from community versus clinic cohorts JAD 18 2009 691 701
32. H.C. Chui, C. Zarow, and W.J. Mack Cognitive impact of subcortical vascular and Alzheimer's disease pathology Ann Neurol 60 2006 677 687
33. R. Peila, B.L. Rodriguez, L.J. Launer Honolulu-Asia Aging Study Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study Diabetes 51 2002 1256 1262
34. G.A. Dore, M.F. Elias, and M.A. Robbins Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study Diabetologia 52 2009 2551 2560
35. C. Messier Diabetes, Alzheimer's disease and apolipoprotein genotype Exp Gerontol 38 2003 941 946
36. Y. Olsson, A. Brun, and E. Englund Fundamental pathological lesions in vascular dementia Acta Neurol Scand Suppl 168 1996 31 38